NCT01587391View on ClinicalTrials.gov

Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 163538 XX

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Healthy
Interventions
DRUG

Placebo to BI 163538 XX

1 single dose per subject as oral solution

DRUG

BI 163538 XX

1 single dose per subject as oral solution

Trial Locations (1)

Unknown

1291.1.1 Boehringer Ingelheim Investigational Site, Neuss

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY